D W Nebert

发表

A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases

R G H Cotton, A D Auerbach, A F Brown, 2007, Human mutation.

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

D W Nebert, A Bairoch, J Magdalou, 1997, Pharmacogenetics.

Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.

D W Nebert, D. Nebert, T. Dalton, 2000, Biochemical and biophysical research communications.

The P450 gene superfamily: recommended nomenclature.

D W Nebert, M. J. Coon, R. Estabrook, 1987, DNA.

Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions.

D W Nebert, D. Nebert, 1991, Molecular endocrinology.

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

D W Nebert, M. J. Coon, O. Gotoh, 1996, Pharmacogenetics.

Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology.

D W Nebert, D. Nebert, 2000, Pharmacogenetics.

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

D W Nebert, Y Fujii-Kuriyama, D R Nelson, 1991, DNA and cell biology.

Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

D W Nebert, H. Li, S. Potter, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species.

D W Nebert, D. Nebert, M. Sato, 1978, The Journal of biological chemistry.

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.

D W Nebert, D. Nebert, A. Puga, 1996, DNA and cell biology.

The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects.

D W Nebert, D. Nebert, 1989, Critical reviews in toxicology.

P450 genes: structure, evolution, and regulation.

D W Nebert, D. Nebert, F. Gonzalez, 1987, Annual review of biochemistry.

Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16.

D W Nebert, D. Nebert, O. Mcbride, 1988, The Journal of biological chemistry.

Pharmacogenomics: out of the lab and into the community.

D W Nebert, D. Nebert, E. Bingham, 2001, Trends in Biotechnology.

Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics.

D W Nebert, D. Nebert, D. W. Nebert, 2000, European journal of pharmacology.